Better Therapeutics Inc. is a digital therapeutics company focused on developing prescription digital therapies to treat cardiometabolic diseases. The company integrates cognitive behavioral therapy (CBT) with digital platforms, aiming to provide healthcare solutions that can be prescribed by physicians. A key aspect of its offerings is the utilization of software-based treatment methodologies that are designed to modify behavior and assist in managing conditions such as diabetes, hypertension, and chronic kidney disease. Better Therapeutics operates at the intersection of technology and healthcare, contributing to the growing field of digital health solutions that offer personalized treatment plans without the need for traditional pharmaceuticals. Founded in 2015 and headquartered in San Francisco, California, Better Therapeutics plays a significant role in advancing healthcare innovation by addressing unmet medical needs through digital intervention. Its efforts reflect a shift towards preventive care and the application of behavioral sciences in clinical practice, demonstrating the increasing importance of technology in managing chronic health conditions.